STAAR SURGICAL COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.53 USD | +2.29% |
|
+0.90% | +33.07% |
| May. 08 | Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating | MT |
| May. 08 | Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating | MT |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the STAAR Surgical First...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Companyâs EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Calendar
2024-06-20
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
41.53
USD
Average target price
52.31
USD
Spread / Average Target
+25.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +33.07% | 2.04B | |
| -7.16% | 178B | |
| -4.86% | 67.04B | |
| -4.28% | 47.24B | |
| +10.32% | 44.62B | |
| +8.14% | 42.5B | |
| +15.76% | 29.99B | |
| +15.53% | 25.22B | |
| -5.88% | 24.14B | |
| -5.38% | 23.69B |
- Stock Market
- Equities
- STAA Stock
- News STAAR Surgical Company
- Transcript : STAAR Surgical Company, Q1 2024 Earnings Call, May 07, 2024
